ALGS
Price
$33.01
Change
-$1.46 (-4.24%)
Updated
Dec 18, 04:59 PM (EDT)
ANNX
Price
$4.96
Change
+$0.07 (+1.43%)
Updated
Dec 18, 04:59 PM (EDT)
92 days until earnings call
Ad is loading...

ALGS vs ANNX

Header iconALGS vs ANNX Comparison
Open Charts ALGS vs ANNXBanner chart's image
Aligos Therapeutics
Price$33.01
Change-$1.46 (-4.24%)
Volume$2.15K
CapitalizationN/A
Annexon
Price$4.96
Change+$0.07 (+1.43%)
Volume$136.1K
CapitalizationN/A
ALGS vs ANNX Comparison Chart
Loading...
ALGS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALGS vs. ANNX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGS is a Hold and ANNX is a StrongBuy.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (ALGS: $34.47 vs. ANNX: $4.88)
Brand notoriety: ALGS and ANNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALGS: 146% vs. ANNX: 138%
Market capitalization -- ALGS: $123.67M vs. ANNX: $520.18M
ALGS [@Biotechnology] is valued at $123.67M. ANNX’s [@Biotechnology] market capitalization is $520.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGS’s FA Score shows that 0 FA rating(s) are green whileANNX’s FA Score has 1 green FA rating(s).

  • ALGS’s FA Score: 0 green, 5 red.
  • ANNX’s FA Score: 1 green, 4 red.
According to our system of comparison, ALGS is a better buy in the long-term than ANNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGS’s TA Score shows that 4 TA indicator(s) are bullish while ANNX’s TA Score has 5 bullish TA indicator(s).

  • ALGS’s TA Score: 4 bullish, 4 bearish.
  • ANNX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ANNX is a better buy in the short-term than ALGS.

Price Growth

ALGS (@Biotechnology) experienced а +11.84% price change this week, while ANNX (@Biotechnology) price change was +0.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

ALGS is expected to report earnings on Nov 06, 2024.

ANNX is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANNX($520M) has a higher market cap than ALGS($124M). ALGS YTD gains are higher at: 107.651 vs. ANNX (7.489). ALGS has higher annual earnings (EBITDA): -91.86M vs. ANNX (-129.45M). ANNX has more cash in the bank: 340M vs. ALGS (74.9M). ALGS has less debt than ANNX: ALGS (9.13M) vs ANNX (29.6M). ALGS has higher revenues than ANNX: ALGS (6M) vs ANNX (0).
ALGSANNXALGS / ANNX
Capitalization124M520M24%
EBITDA-91.86M-129.45M71%
Gain YTD107.6517.4891,437%
P/E RatioN/AN/A-
Revenue6M0-
Total Cash74.9M340M22%
Total Debt9.13M29.6M31%
TECHNICAL ANALYSIS
Technical Analysis
ALGSANNX
RSI
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 8 days ago
79%
Bullish Trend 20 days ago
84%
Declines
ODDS (%)
Bearish Trend 29 days ago
90%
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
ALGS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IVAEX22.32-0.08
-0.36%
Delaware Ivy Asset Strategy Fund Cl I
BOYAX31.14-0.12
-0.38%
Boyar Value
DIVHX27.08-0.13
-0.48%
Cutler Equity Fund
JFCCX35.35-0.30
-0.84%
JHancock Fundamental All Cap Core C
DCCIX31.55-0.40
-1.25%
Delaware Small Cap Core I

ALGS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGS has been loosely correlated with STRO. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGS jumps, then STRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGS
1D Price
Change %
ALGS100%
+2.41%
STRO - ALGS
39%
Loosely correlated
+0.97%
CNSP - ALGS
27%
Poorly correlated
+8.74%
RLAY - ALGS
26%
Poorly correlated
-7.02%
ANNX - ALGS
26%
Poorly correlated
-3.56%
CYTK - ALGS
26%
Poorly correlated
-2.53%
More

ANNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANNX has been loosely correlated with MGTX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ANNX jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANNX
1D Price
Change %
ANNX100%
-3.56%
MGTX - ANNX
45%
Loosely correlated
+1.91%
DNTH - ANNX
41%
Loosely correlated
+1.00%
FDMT - ANNX
40%
Loosely correlated
-2.47%
FULC - ANNX
40%
Loosely correlated
+2.71%
XENE - ANNX
39%
Loosely correlated
-0.07%
More